4//SEC Filing
PAUL LAURENCE E 4
Accession 0000885590-12-000034
CIK 0000885590other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:51 PM ET
Size
6.4 KB
Accession
0000885590-12-000034
Insider Transaction Report
Form 4
PAUL LAURENCE E
Director
Transactions
- Purchase
Common Shares, no par value
2012-05-25$48.60/sh+5,000$243,000→ 47,397 total - Purchase
Common Shares, no par value
2012-05-29$48.00/sh+700$33,600→ 48,097 total
Footnotes (1)
- [F1]This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001190966
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 4:51 PM ET
- Size
- 6.4 KB